Metronome LLC v. Abacus Health Products: Cannabis Patent Dismissal in 45 Days

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

📋 Case Summary

Case Name Metronome LLC v. Abacus Health Products, Inc.
Case Number 1:25-cv-00274 (D. Del.)
Court U.S. District Court for the District of Delaware
Duration March 2025 – April 2025 45 days
Outcome Dismissed with Prejudice – Parties Bear Own Costs
Patents at Issue
Accused Products Abacus Health Products’ Line of Cannabis-Derived Topical Treatments

Case Overview

The Parties

⚖️ Plaintiff

Patent holder asserting rights over cannabis-derived topical formulations, reflecting a trend of IP monetization in the cannabis therapeutics space.

🛡️ Defendant

Recognized player in the consumer wellness market, known for CBD-based topical products marketed under established retail channels.

Patent at Issue

This landmark case centered on U.S. Patent No. 10,653,736 B2, covering topical treatments incorporating cannabis-derived botanical drug products.

🔍

Developing a cannabis topical product?

Check if your formulation might infringe this or related patents.

Run FTO Check →

The Verdict & Legal Analysis

Outcome

Metronome LLC filed a voluntary dismissal with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i) on April 21, 2025. All claims against Abacus Health Products were dismissed with prejudice, with each party bearing its own costs, expenses, and attorneys’ fees. No damages were awarded, and no injunctive relief was granted.

Key Legal Issues

The case resolved before any substantive motion practice, including judicial claim construction, validity rulings, or infringement findings. The invocation of Rule 41(a)(1)(A)(i) before an answer or summary judgment motion prevents Metronome from re-filing the same claims against Abacus Health Products on U.S. Patent No. 10,653,736 B2.

✍️

Filing a cannabis patent?

Learn from this case. Use AI to draft stronger claims for botanical drug products.

Try Patent Drafting →

Power Your Patent Strategy with PatSnap Eureka IP

From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.

⚠️ Freedom to Operate (FTO) Analysis in Cannabis IP

This case highlights critical IP risks in cannabis topical product development. Choose your next step:

📋 Understand This Case’s Impact

Learn about the specific risks and implications for cannabis topicals from this litigation.

  • View active cannabis patent litigation trends
  • See other companies active in cannabis IP assertion
  • Understand claim construction patterns for botanical drugs
📊 View Cannabis Patent Landscape
⚠️
High Risk Area

Cannabis-derived topical formulations

📋
U.S. 10,653,736 B2 Active

Key patent for botanical topicals

Early Resolution Value

Swift dismissal possible with engagement

✅ Key Takeaways

For Patent Attorneys & Litigators

Rule 41(a)(1)(A)(i) dismissals with prejudice permanently bar re-assertion against the same defendant.

Search related case law →

Delaware remains the preferred venue for cannabis IP litigation, offering procedural predictability.

Explore precedents →

For IP Professionals

Cannabis topical patent assertion is an active and growing enforcement area — portfolio monitoring is essential.

Monitor cannabis IP trends →

Early-stage settlement or licensing discussions can achieve favorable outcomes before substantial litigation spend.

Explore licensing strategies →

For R&D Leaders

Conduct FTO analysis on cannabis-derived topical formulations, specifically against granted patents in this family.

Start FTO analysis for my product →

Design-around strategies should be evaluated at the formulation development stage, not post-litigation filing.

Try AI patent drafting →

Ready to Strengthen Your Patent Strategy?

Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.

⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.